Iacovelli L, Capobianco L, Iula M, Di Giorgi Gerevini V, Picascia A, Blahos J, Melchiorri D, Nicoletti F, De Blasi A
Dept. of Human Physiology and Pharmacology, University of Rome La Sapienza, Italy.
Mol Pharmacol. 2004 May;65(5):1103-10. doi: 10.1124/mol.65.5.1103.
We examined the role of G-protein coupled receptor kinase-2 (GRK2) in the homologous desensitization of mGlu4 metabotropic glutamate receptors transiently expressed in human embryonic kidney (HEK) 293 cells. Receptor activation with the agonist l-2-amino-4-phosphonobutanoate (l-AP4) stimulated at least two distinct signaling pathways: inhibition of cAMP formation and activation of the mitogen-activated protein kinase (MAPK) pathway [assessed by Western blot analysis of phosphorylated extracellular signal-regulated kinase (ERK) 1 and 2]. Activation of both pathways was attenuated by pertussis toxin. Overexpression of GRK2 (but not GRK4) largely attenuated the stimulation of the MAPK pathway by l-AP4, whereas it slightly potentiated the inhibition of FSK-stimulated cAMP formation. Transfection with a kinase-dead mutant of GRK2 (GRK2-K220R) or with the C-terminal fragment of GRK2 also reduced the mGlu4-mediated stimulation of MAPK, suggesting that GRK2 binds to the Gbetagamma subunits to inhibit signal propagation toward the MAPK pathway. This was confirmed by the evidence that GRK2 coimmunoprecipitated with Gbetagamma subunits in an agonist-dependent manner. Finally, neither GRK2 nor its kinase-dead mutant had any effect on agonist-induced mGlu4 receptor internalization in HEK293 cells transiently transfected with GFP-tagged receptors. Agonist-dependent internalization was instead abolished by a negative-dominant mutant of dynamin, which also reduced the stimulation of MAPK pathway by l-AP4. We speculate that GRK2 acts as a "switch molecule" by inhibiting the mGlu4 receptor-mediated stimulation of MAPK and therefore directing the signal propagation toward the inhibition of adenylyl cyclase.
我们研究了G蛋白偶联受体激酶2(GRK2)在人胚肾(HEK)293细胞中瞬时表达的代谢型谷氨酸受体mGlu4同源脱敏中的作用。用激动剂L-2-氨基-4-膦酰丁酸(L-AP4)激活受体可刺激至少两条不同的信号通路:抑制cAMP形成和激活丝裂原活化蛋白激酶(MAPK)通路[通过对磷酸化细胞外信号调节激酶(ERK)1和2进行蛋白质印迹分析来评估]。百日咳毒素减弱了这两条通路的激活。GRK2(而非GRK4)的过表达在很大程度上减弱了L-AP4对MAPK通路的刺激,而它略微增强了对FSK刺激的cAMP形成的抑制。用GRK2的激酶失活突变体(GRK2-K220R)或GRK2的C末端片段转染也减少了mGlu4介导的MAPK刺激,这表明GRK2与Gβγ亚基结合以抑制信号向MAPK通路的传播。GRK2与Gβγ亚基以激动剂依赖的方式共免疫沉淀这一证据证实了这一点。最后,在瞬时转染了绿色荧光蛋白标记受体的HEK293细胞中,GRK2及其激酶失活突变体对激动剂诱导的mGlu4受体内化均无任何影响。相反,发动蛋白的负显性突变体消除了激动剂依赖的内化,该突变体也减少了L-AP4对MAPK通路的刺激。我们推测,GRK2通过抑制mGlu4受体介导的MAPK刺激而充当“开关分子”,从而引导信号传播至对腺苷酸环化酶的抑制。